Exploring the Active Sites of Cholinesterases by Inhibition with Bambuterol and Haloxon
Zrinka Kovarik
orcid.org/0000-0001-9863-886X
; Institute for Medical Research and Occupational Health, Ksaverska c. 2, POB 291, HR-10001 Zagreb, Croatia
Anita Bosak
orcid.org/0000-0003-0164-4994
; Institute for Medical Research and Occupational Health, Ksaverska c. 2, POB 291, HR-10001 Zagreb, Croatia
Goran Šinko
; Institute for Medical Research and Occupational Health, Ksaverska c. 2, POB 291, HR-10001 Zagreb, Croatia
Tatjana Latas
; Institute for Medical Research and Occupational Health, Ksaverska c. 2, POB 291, HR-10001 Zagreb, Croatia
APA 6th Edition Kovarik, Z., Bosak, A., Šinko, G. i Latas, T. (2003). Exploring the Active Sites of Cholinesterases by Inhibition with Bambuterol and Haloxon. Croatica Chemica Acta, 76 (1), 63-67. Preuzeto s https://hrcak.srce.hr/103058
MLA 8th Edition Kovarik, Zrinka, et al. "Exploring the Active Sites of Cholinesterases by Inhibition with Bambuterol and Haloxon." Croatica Chemica Acta, vol. 76, br. 1, 2003, str. 63-67. https://hrcak.srce.hr/103058. Citirano 09.03.2021.
Chicago 17th Edition Kovarik, Zrinka, Anita Bosak, Goran Šinko i Tatjana Latas. "Exploring the Active Sites of Cholinesterases by Inhibition with Bambuterol and Haloxon." Croatica Chemica Acta 76, br. 1 (2003): 63-67. https://hrcak.srce.hr/103058
Harvard Kovarik, Z., et al. (2003). 'Exploring the Active Sites of Cholinesterases by Inhibition with Bambuterol and Haloxon', Croatica Chemica Acta, 76(1), str. 63-67. Preuzeto s: https://hrcak.srce.hr/103058 (Datum pristupa: 09.03.2021.)
Vancouver Kovarik Z, Bosak A, Šinko G, Latas T. Exploring the Active Sites of Cholinesterases by Inhibition with Bambuterol and Haloxon. Croatica Chemica Acta [Internet]. 2003 [pristupljeno 09.03.2021.];76(1):63-67. Dostupno na: https://hrcak.srce.hr/103058
IEEE Z. Kovarik, A. Bosak, G. Šinko i T. Latas, "Exploring the Active Sites of Cholinesterases by Inhibition with Bambuterol and Haloxon", Croatica Chemica Acta, vol.76, br. 1, str. 63-67, 2003. [Online]. Dostupno na: https://hrcak.srce.hr/103058. [Citirano: 09.03.2021.]
Sažetak The paper describes the inhibition of mouse acetylcholinesterase (AChE; EC 3.1.1.7) and mouse, human, and horse butyrylcholinesterase (BChE; EC 3.1.1.8) by 5-[2-(tert-butylamino)-1-hydroxyethyl]-m-phenylene-bis(dimethylcarbamate) hydrochloride (bambuterol) and by O,O-bis-(2-chloroethyl)-O-(3-chloro-4-methylcoumarin-7-yl) phosphate (haloxon). The haloxon inhibition rate constant (ki) for mouse BChE was 3.7 × 107 min–1 mol–1 dm3, which was 40-fold higher than the rate constant for mouse AChE. Bambuterol inhibition of horse BChE (ki = 2.1 × 105 min–1 mol–1 dm3) was about 25-fold slower than that of human or mouse BChE, whereas the respective haloxon inhibition of horse BChE (ki = 1.2 × 107 min–1 mol–1 dm3) was about 2-3-fold slower. Sequence alignments and the computational model of the three-dimensional structure of horse BChE suggest that residues inside the active site at positions 69, 277 and 285 are important for the differences in the inhibition of these three BChE species.